PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics, Inc. is a biotechnology company, which specializes in the discovery and development of therapeutics to treat central nervous system disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$5.82    OTCQB
As of 04/09/2021     OTCMarkets

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  12/18/1996
Outstanding shares:  10,521,506
Average volume:  0
Market cap:   $61,235,165
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   -28.38
PS ratio:   0.00
Return on equity:   229.24%
Net income %:   0.00%